517 related articles for article (PubMed ID: 12397035)
1. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
2. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
3. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
4. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
Datta PK; Moses HL
Mol Cell Biol; 2000 May; 20(9):3157-67. PubMed ID: 10757800
[TBL] [Abstract][Full Text] [Related]
5. Localization of Smad6 and Smad7 in the rat kidney and their regulated expression in the anti-Thy-1 nephritis.
Uchida K; Nitta K; Kobayashi H; Kawachi H; Shimizu F; Yumura W; Nihei H
Mol Cell Biol Res Commun; 2000 Aug; 4(2):98-105. PubMed ID: 11170839
[TBL] [Abstract][Full Text] [Related]
6. Mechanical stretch down-regulates expression of the Smad6 gene in cultured rat mesangial cells.
Hayashi Y; Katoh T; Asano K; Onozaki A; Sakurai K; Asahi K; Nakayama M; Watanabe T
Clin Exp Nephrol; 2012 Oct; 16(5):690-6. PubMed ID: 22581061
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in podocytes induced by TGF-beta and Smad7.
Schiffer M; Bitzer M; Roberts IS; Kopp JB; ten Dijke P; Mundel P; Böttinger EP
J Clin Invest; 2001 Sep; 108(6):807-16. PubMed ID: 11560950
[TBL] [Abstract][Full Text] [Related]
8. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
9. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
10. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells.
Okado T; Terada Y; Tanaka H; Inoshita S; Nakao A; Sasaki S
Kidney Int; 2002 Oct; 62(4):1178-86. PubMed ID: 12234288
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of Smad7 inhibits transforming growth factor-beta responses in vascular smooth muscle cells.
Kato S; Ueda S; Tamaki K; Fujii M; Miyazono K; ten Dijke P; Morimatsu M; Okuda S
Life Sci; 2001 Oct; 69(22):2641-52. PubMed ID: 11712667
[TBL] [Abstract][Full Text] [Related]
12. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation.
Choy L; Skillington J; Derynck R
J Cell Biol; 2000 May; 149(3):667-82. PubMed ID: 10791980
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
14. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells.
Kanamaru Y; Nakao A; Tanaka Y; Inagaki Y; Ushio H; Shirato I; Horikoshi S; Okumura K; Ogawa H; Tomino Y
Nephron Exp Nephrol; 2003; 95(1):e36-42. PubMed ID: 14520013
[TBL] [Abstract][Full Text] [Related]
16. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.
Li JH; Huang XR; Zhu HJ; Johnson R; Lan HY
Kidney Int; 2003 Jun; 63(6):2010-9. PubMed ID: 12753288
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
18. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
19. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
20. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]